Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1986-1-3
pubmed:abstractText
We have used the expression of the muscle form of creatine phosphokinase (M-CPK) to assay myogenic differentiation in the cloned muscle cell line BC3Hl. BC3Hl cells express M-CPK when arrested in the G0 portion of the cell cycle. Addition of the anionic form of brain fibroblast growth factor (B-FGF) rapidly represses synthesis of M-CPK with a half-time of 7 h. Even though B-FGF is not mitogenic for the cells, it causes quiescent BC3Hl cells to exit from the G0 portion of the cell cycle, and to accumulate at a new restriction point approximately 4 to 6 h in the G1 portion of the cell cycle. The repression of M-CPK synthesis by B-FGF is reversible upon removal of B-FGF, and cells which have re-initiated expression of M-CPK have also returned to the G0 portion of the cell cycle. The primary control of M-CPK expression by B-FGF appears to be at the level of gene transcription. We conclude that arrest of cells at G0 but not at other positions in the G1 phase of the cell cycle provides permissive conditions for the expression of muscle-specific proteins, and that defined polypeptide growth factors, in this case B-FGF, are important in the control of the expression of muscle-specific proteins.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/4066754-196284, http://linkedlifedata.com/resource/pubmed/commentcorrection/4066754-332455, http://linkedlifedata.com/resource/pubmed/commentcorrection/4066754-354504, http://linkedlifedata.com/resource/pubmed/commentcorrection/4066754-3885045, http://linkedlifedata.com/resource/pubmed/commentcorrection/4066754-3982504, http://linkedlifedata.com/resource/pubmed/commentcorrection/4066754-3988800, http://linkedlifedata.com/resource/pubmed/commentcorrection/4066754-4363958, http://linkedlifedata.com/resource/pubmed/commentcorrection/4066754-4636326, http://linkedlifedata.com/resource/pubmed/commentcorrection/4066754-6174983, http://linkedlifedata.com/resource/pubmed/commentcorrection/4066754-6337159, http://linkedlifedata.com/resource/pubmed/commentcorrection/4066754-6591194, http://linkedlifedata.com/resource/pubmed/commentcorrection/4066754-6683997, http://linkedlifedata.com/resource/pubmed/commentcorrection/4066754-670306, http://linkedlifedata.com/resource/pubmed/commentcorrection/4066754-6825923, http://linkedlifedata.com/resource/pubmed/commentcorrection/4066754-7085777, http://linkedlifedata.com/resource/pubmed/commentcorrection/4066754-7107711, http://linkedlifedata.com/resource/pubmed/commentcorrection/4066754-786151
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0021-9525
pubmed:author
pubmed:issnType
Print
pubmed:volume
101
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2194-8
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1985
pubmed:articleTitle
Control of myogenic differentiation by fibroblast growth factor is mediated by position in the G1 phase of the cell cycle.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't